Enliven Therapeutics Inc (NASDAQ:ELVN): -33.64% Off High, Can It Comeback?
In last trading session, Enliven Therapeutics Inc (NASDAQ:ELVN) saw 0.4 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price